Company: PTHS
Filing Date: 2025-11-25
Form Type: DEF 14A
Source: 0001753926-25-001827
Chunk: 32

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-25
Form: DEF 14A
Chunk 32
---
 — |     | —           |     |   |    13.00 |     | 6/14/2024  |     | —                      |     |   | —                      |     | —              |     |   | —         |
| Sai Rangarao,               
 Chief Commercial Officer    |     |           — |     |             — |     | —           |     |   |        — |     | —          |     | —                      |     |   | -                      |     | -              |     |   | -         |
| Eric Lang, Chief            
 Medical Officer             |     |      10,093 |     |        14,130 |     | —           |     | $ |   226.80 |     | 5/15/2033  |     | —                      |     | $ | —                      |     | —              |     | $ | —         |
| Eric Lang, Chief            
 Medical Officer             |     |      32,500 |     |        97,500 |     | —           |     | $ |    13.00 |     | 6/14/2034  |     | —                      |     |   | —                      |     | —              |     |   | —         |

Equity Incentive Plan

The Pelthos Therapeutics Inc. Amended and Restated 2023 Equity Incentive Plan

On January 10, 2023, the Channel board of directors adopted and submitted for shareholder approval the Channel Therapeutics 2023 Equity Incentive Plan (the “Prior Plan”), which Prior Plan was later approved by the Company’s shareholders. On February 15, 2023, we amended the Prior Plan to increase the number of shares available for issuance thereunder to 44,445 and on October 22, 2024, we further amended the Prior Plan to increase the number of shares available for issuance thereunder to 194,445. The following summary of the material features of the Prior Plan is qualified in its entirety by reference to the complete text of the Prior Plan. The Prior Plan will terminate on January 10, 2033, in accordance with its terms, although, awards outstanding under the Prior Plan will continue to be governed by their existing terms after the Prior Plan’s expiration.

<div align='center'>20</div>

On April 11, 2025, the Channel board of directors adopted a resolution approving the Pelthos